Search research articles
Contact Us
Filters
Showing results (961-970 of 1,509) with videos related to
Page
of 151
Sort By:
ESMO Open
|
December 20, 2021
Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies
A S Berghoff, C Sessa, J C-H Yang, et al.
Nature Communications
|
January 12, 2018
Author Correction: Signatures of the topological s<sup>+-</sup> superconducting order parameter in the type-II Weyl semimetal T <sub>d</sub> -MoTe<sub>2</sub>
Z Guguchia, F von Rohr, Z Shermadini, et al.
Nature Communications
|
October 24, 2017
Signatures of the topological s <sup>+-</sup> superconducting order parameter in the type-II Weyl semimetal T <sub>d</sub>-MoTe<sub>2</sub>
Z Guguchia, F von Rohr, Z Shermadini, et al.
ESMO Open
|
February 26, 2023
Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey
H Linardou, A A Adjei, J Bajpai, et al.
Mymensingh Medical Journal : MMJ
|
August 19, 2007
Evaluation of stentangioplasty in university cardiac center
F Rahman, S Banerjee, C M Ahmed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2018
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
S Banerjee, A M Oza, M J Birrer, et al.
The Journal of Clinical Investigation
|
November 5, 2020
Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms
Olurotimi O Mesubi, Adam G Rokita, Neha Abrol, et al.
Indian Heart Journal
|
December 5, 2023
CSI clinical practice guidelines for dyslipidemia management: Executive summary
Jitendra Ps Sawhney, Sivasubramanian Ramakrishnan, Kushal Madan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
B Basu, M G Krebs, R Sundar, et al.
ESMO Open
|
July 10, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation
S Peters, M-L Meyer, F André, et al.
Page
of 151
Search research articles
Search
Showing results (961-970 of 1,509) with videos related to
Sort By:
Page
of 151
ESMO Open
|
December 20, 2021
Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies
A S Berghoff, C Sessa, J C-H Yang, et al.
Nature Communications
|
January 12, 2018
Author Correction: Signatures of the topological s<sup>+-</sup> superconducting order parameter in the type-II Weyl semimetal T <sub>d</sub> -MoTe<sub>2</sub>
Z Guguchia, F von Rohr, Z Shermadini, et al.
Nature Communications
|
October 24, 2017
Signatures of the topological s <sup>+-</sup> superconducting order parameter in the type-II Weyl semimetal T <sub>d</sub>-MoTe<sub>2</sub>
Z Guguchia, F von Rohr, Z Shermadini, et al.
ESMO Open
|
February 26, 2023
Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey
H Linardou, A A Adjei, J Bajpai, et al.
Mymensingh Medical Journal : MMJ
|
August 19, 2007
Evaluation of stentangioplasty in university cardiac center
F Rahman, S Banerjee, C M Ahmed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2018
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
S Banerjee, A M Oza, M J Birrer, et al.
The Journal of Clinical Investigation
|
November 5, 2020
Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms
Olurotimi O Mesubi, Adam G Rokita, Neha Abrol, et al.
Indian Heart Journal
|
December 5, 2023
CSI clinical practice guidelines for dyslipidemia management: Executive summary
Jitendra Ps Sawhney, Sivasubramanian Ramakrishnan, Kushal Madan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer
B Basu, M G Krebs, R Sundar, et al.
ESMO Open
|
July 10, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation
S Peters, M-L Meyer, F André, et al.
Page
of 151